Free Stock & ETF Comparisons
2300+ side-by-side comparisons with AI scores, valuation metrics, performance charts, analyst targets, and investor takeaways. No sign-in required.
- AI investment scores (0–100) for each stock
- Valuation metrics: P/E, forward P/E, PEG, EV/EBITDA
- Performance charts across 1M to 10Y timeframes
- Analyst price targets and upside estimates
- AI-written investor thesis and side-by-side takeaways
Browse Comparisons
Compare AeroVironment's drone hardware business against CACI's defense IT and intelligence services model on margins and backlog.
Compare AeroVironment and Kratos Defense on unmanned systems exposure, backlog growth, and valuation.
Compare AeroVironment's fast-growing drone business against Lockheed Martin's scale, backlog, and dividend profile.
Compare AeroVironment's autonomous-systems growth against RTX's diversified aerospace and defense portfolio.
Compare Axon's TASER and body-camera SaaS platform against CACI's defense IT services on growth and margins.
Compare Ares Capital and Blue Owl Capital Corporation by NAV stability, dividend coverage, portfolio quality, and yield.
Compare Ares Capital's diversified private-credit book against Hercules Capital's venture-lending focus on yield and risk.
Compare Ares Capital and FS KKR Capital by NAV-per-share trend, non-accrual rates, and dividend sustainability.
Compare Main Street Capital's lower/middle-market lending model against Hercules Capital's venture-debt focus on yield and premium-to-NAV.
Compare Main Street Capital and Prospect Capital by dividend track record, NAV stability, and portfolio credit quality.
Compare BlackRock and Invesco by AUM growth, fee compression, ETF market share, and margin profile.
Compare BlackRock's iShares-driven scale against Franklin Resources' active-management turnaround on flows and valuation.
Compare U.S. Bancorp and Truist Financial by net interest margin, efficiency ratio, credit quality, and dividend yield.
Compare U.S. Bancorp and M&T Bank by loan growth, deposit costs, capital ratios, and valuation.
Compare Travelers and The Hartford by combined ratio, catastrophe exposure, pricing power, and book value growth.
Compare Travelers and AIG by underwriting discipline, reserve strength, capital return, and valuation.
Compare S&P Global's ratings/index duopoly economics against FactSet's subscription analytics model on growth and margins.
Compare Moody's ratings and analytics business against FactSet's terminal/subscription model on recurring revenue quality.
Compare S&P Global's ratings and indices business against ICE's exchange and fixed-income data platform.
Compare Moody's credit-ratings duopoly economics against MSCI's index-licensing recurring-revenue model.
Compare Mobileye's ADAS/autonomous-driving pure-play against Qualcomm's diversified automotive and mobile chip business.
Compare Mobileye's ADAS software/silicon platform against ON Semiconductor's power and sensing chips for EVs and ADAS.
Compare Mobileye's supply-to-many-OEMs model against Tesla's vertically integrated self-driving and robotaxi ambitions.
Compare Pan American Silver's silver-leveraged production against Newmont's gold-dominant portfolio on cost structure and leverage to metal prices.
Compare Pan American Silver and First Majestic Silver by all-in sustaining costs, reserve life, and silver-price leverage.
Compare Pan American Silver's diversified Americas footprint against Coeur Mining's US-focused operations on costs and balance sheet.
Compare NexGen Energy's pre-production Rook I project against Cameco's established, producing uranium business.
Compare NexGen Energy's high-grade Athabasca Basin deposit against Uranium Energy Corp's US in-situ recovery production.
Compare Uranium Energy Corp's US-based in-situ recovery growth against Cameco's global scale and long-term contract book.
Compare NexGen Energy and Denison Mines by project stage, resource grade, and capital requirements in the Athabasca Basin.
Compare Uranium Energy Corp's production-stage US assets against Denison Mines' Canadian development-stage project.
Compare Halliburton's completions and drilling services against NOV's equipment manufacturing on cycle exposure and margins.
Compare EOG Resources and Diamondback Energy by breakeven costs, capital discipline, and free cash flow yield.
Compare EOG Resources and Devon Energy by drilling inventory, dividend framework, and cash returns to shareholders.
Compare Kinder Morgan's natural gas pipeline network against ONEOK's NGL and gathering/processing footprint on contract mix and yield.
Compare Kinder Morgan's take-or-pay pipeline contracts against Targa Resources' NGL-exposed growth profile.
Compare Dominion Energy and American Electric Power by rate-base growth, data-center demand exposure, and dividend coverage.
Compare Dominion Energy's rate-base growth against PG&E's wildfire-liability turnaround story on risk and valuation.
Compare American Electric Power and Entergy by data-center load growth, capex plans, and regulated ROE.
Compare Elevance Health's Medicaid/Medicare Advantage mix against Cigna's PBM-heavy model on medical loss ratio and growth.
Compare Elevance Health and UnitedHealth Group by membership growth, Optum-style diversification, and valuation discount.
Compare Elevance Health and Humana by Medicare Advantage star ratings, membership trends, and medical cost ratio.
Compare Elevance Health's pure managed-care model against CVS Health's pharmacy-plus-insurance (Aetna) integration.
Compare DexCom's continuous glucose monitoring pure-play against Medtronic's diversified device portfolio on growth and margins.
Compare Stryker's orthopedics and surgical-equipment franchise against Boston Scientific's cardiovascular and endoscopy portfolio.
Compare Stryker's broad orthopedics/MedSurg portfolio against Intuitive Surgical's da Vinci robotic-surgery platform economics.
Compare Boston Scientific's cardiovascular device pipeline against Abbott's diversified devices, diagnostics, and nutrition business.
Compare ADP's entrenched payroll/PEO scale against Workday's cloud-native HR and finance software growth.
Sign in to access the full platform — compare any stocks, build watchlists, and get AI-powered portfolio insights.
Start Free Trial